These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. TERT-Promoter Mutational Status in Glioblastoma - Is There an Association With Amino Acid Uptake on Dynamic Unterrainer M; Ruf V; von Rohr K; Suchorska B; Mittlmeier LM; Beyer L; Brendel M; Wenter V; Kunz WG; Bartenstein P; Herms J; Niyazi M; Tonn JC; Albert NL Front Oncol; 2021; 11():645316. PubMed ID: 33996563 [TBL] [Abstract][Full Text] [Related]
3. Non-invasive prediction of IDH-wildtype genotype in gliomas using dynamic Vettermann F; Suchorska B; Unterrainer M; Nelwan D; Forbrig R; Ruf V; Wenter V; Kreth FW; Herms J; Bartenstein P; Tonn JC; Albert NL Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2581-2589. PubMed ID: 31410540 [TBL] [Abstract][Full Text] [Related]
4. Characterization of Diffuse Gliomas With Histone H3-G34 Mutation by MRI and Dynamic 18F-FET PET. Vettermann FJ; Felsberg J; Reifenberger G; Hasselblatt M; Forbrig R; Berding G; la Fougère C; Galldiks N; Schittenhelm J; Weis J; Albert NL; Schüller U Clin Nucl Med; 2018 Dec; 43(12):895-898. PubMed ID: 30358620 [TBL] [Abstract][Full Text] [Related]
5. Comparison of Unterrainer M; Fleischmann DF; Diekmann C; Vomacka L; Lindner S; Vettermann F; Brendel M; Wenter V; Ertl-Wagner B; Herms J; Wetzel C; Rupprecht R; Tonn JC; Belka C; Bartenstein P; Niyazi M; Albert NL Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):580-590. PubMed ID: 30244386 [TBL] [Abstract][Full Text] [Related]
6. Fleischmann DF; Unterrainer M; Bartenstein P; Belka C; Albert NL; Niyazi M J Neurooncol; 2017 Apr; 132(2):277-286. PubMed ID: 28102485 [TBL] [Abstract][Full Text] [Related]
7. TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative Unterrainer M; Fleischmann DF; Vettermann F; Ruf V; Kaiser L; Nelwan D; Lindner S; Brendel M; Wenter V; Stöcklein S; Herms J; Milenkovic VM; Rupprecht R; Tonn JC; Belka C; Bartenstein P; Niyazi M; Albert NL Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1368-1380. PubMed ID: 31486876 [TBL] [Abstract][Full Text] [Related]
8. Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[ Bauer EK; Stoffels G; Blau T; Reifenberger G; Felsberg J; Werner JM; Lohmann P; Rosen J; Ceccon G; Tscherpel C; Rapp M; Sabel M; Filss CP; Shah NJ; Neumaier B; Fink GR; Langen KJ; Galldiks N Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1486-1495. PubMed ID: 32034446 [TBL] [Abstract][Full Text] [Related]
9. Static Song S; Wang L; Yang H; Shan Y; Cheng Y; Xu L; Dong C; Zhao G; Lu J Eur Radiol; 2021 Jun; 31(6):4087-4096. PubMed ID: 33211141 [TBL] [Abstract][Full Text] [Related]
11. Biological tumour volumes of gliomas in early and standard 20-40 min Unterrainer M; Winkelmann I; Suchorska B; Giese A; Wenter V; Kreth FW; Herms J; Bartenstein P; Tonn JC; Albert NL Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1242-1249. PubMed ID: 29487977 [TBL] [Abstract][Full Text] [Related]
12. Serial 18F-FET PET Imaging of Primarily 18F-FET-Negative Glioma: Does It Make Sense? Unterrainer M; Schweisthal F; Suchorska B; Wenter V; Schmid-Tannwald C; Fendler WP; Schüller U; Bartenstein P; Tonn JC; Albert NL J Nucl Med; 2016 Aug; 57(8):1177-82. PubMed ID: 27033893 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma. Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307 [TBL] [Abstract][Full Text] [Related]
14. Static and dynamic Verger A; Stoffels G; Bauer EK; Lohmann P; Blau T; Fink GR; Neumaier B; Shah NJ; Langen KJ; Galldiks N Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):443-451. PubMed ID: 29043400 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of pre-irradiation FET PET in patients with not completely resectable IDH-wildtype glioma and minimal or absent contrast enhancement. Rosen J; Stoffels G; Lohmann P; Bauer EK; Werner JM; Wollring M; Rapp M; Felsberg J; Kocher M; Fink GR; Langen KJ; Galldiks N Sci Rep; 2021 Oct; 11(1):20828. PubMed ID: 34675225 [TBL] [Abstract][Full Text] [Related]
16. Heterogeneous parameters based on Hua T; Zhou W; Zhou Z; Guan Y; Li M Quant Imaging Med Surg; 2021 Jan; 11(1):317-327. PubMed ID: 33392031 [TBL] [Abstract][Full Text] [Related]
17. Voxel-wise analysis of dynamic Vomacka L; Unterrainer M; Holzgreve A; Mille E; Gosewisch A; Brosch J; Ziegler S; Suchorska B; Kreth FW; Tonn JC; Bartenstein P; Albert NL; Böning G EJNMMI Res; 2018 Sep; 8(1):91. PubMed ID: 30203138 [TBL] [Abstract][Full Text] [Related]
18. Combination of pre-treatment dynamic [ Li Z; Holzgreve A; Unterrainer LM; Ruf VC; Quach S; Bartos LM; Suchorska B; Niyazi M; Wenter V; Herms J; Bartenstein P; Tonn JC; Unterrainer M; Albert NL; Kaiser L Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):535-545. PubMed ID: 36227357 [TBL] [Abstract][Full Text] [Related]
19. Integrated analysis of dynamic FET PET/CT parameters, histology, and methylation profiling of 44 gliomas. Röhrich M; Huang K; Schrimpf D; Albert NL; Hielscher T; von Deimling A; Schüller U; Dimitrakopoulou-Strauss A; Haberkorn U Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1573-1584. PubMed ID: 29732524 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of dynamic 18F-FET PET in newly diagnosed astrocytic high-grade glioma. Jansen NL; Suchorska B; Wenter V; Schmid-Tannwald C; Todica A; Eigenbrod S; Niyazi M; Tonn JC; Bartenstein P; Kreth FW; la Fougère C J Nucl Med; 2015 Jan; 56(1):9-15. PubMed ID: 25537990 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]